中繼療法有限公司
US ˙ NasdaqGM ˙ US75943R1023

SecurityRLAY / Relay Therapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership229,429 shares
Latest Disclosed Value $ 793,824
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 9.43% increase in ownership of RLAY / Relay Therapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 229,429 shares of Relay Therapeutics, Inc. (US:RLAY) valued at $793,824 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 209,651 shares of Relay Therapeutics, Inc.. This represents a change in shares of 9.43% during the quarter. The current value of the position is $3,335,898 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Relay Therapeutics EC US75943R1023 229,429 19,778 9.43 794 44.44 0.0178
2025-05-28 2025-03-31 NP Relay Therapeutics EC US75943R1023 209,651 0 0.00 549 -36.38 0.0132
2025-02-25 2024-12-31 NP Relay Therapeutics EC US75943R1023 209,651 11,320 5.71 864 -38.53 0.0189
2024-11-26 2024-09-30 NP Relay Therapeutics EC US75943R1023 198,331 21,754 12.32 1,404 21.98 0.0266
2024-08-26 2024-06-30 NP Relay Therapeutics EC US75943R1023 176,577 15,283 9.48 1,151 -13.98 0.0234
2024-05-28 2024-03-31 NP Relay Therapeutics EC US75943R1023 161,294 -4,295 -2.59 1,339 -26.60 0.0279
2024-02-26 2023-12-31 NP Relay Therapeutics EC US75943R1023 165,589 15,246 10.14 1,823 44.22 0.0389
2023-11-28 2023-09-30 NP Relay Therapeutics EC US75943R1023 150,343 -6,408 -4.09 1,264 -35.77 0.0330
2023-08-25 2023-06-30 NP Relay Therapeutics EC US75943R1023 156,751 21,428 15.83 1,969 -11.67 0.0467
2023-05-26 2023-03-31 NP Relay Therapeutics EC US75943R1023 135,323 2,356 1.77 2,229 12.19 0.0593
2023-02-24 2022-12-31 NP Relay Therapeutics EC US75943R1023 132,967 7,702 6.15 1,987 -29.12 0.0546
2022-11-25 2022-09-30 NP Relay Therapeutics EC US75943R1023 125,265 7,078 5.99 2,802 41.59 0.0803
2022-08-25 2022-06-30 NP Relay Therapeutics EC US75943R1023 118,187 8,560 7.81 1,980 -39.68 0.0547
2022-05-26 2022-03-31 NP Relay Therapeutics EC US75943R1023 109,627 2,223 2.07 3,281 -0.52 0.0764
2022-02-25 2021-12-31 NP Relay Therapeutics EC US75943R1023 107,404 16,950 18.74 3,298 15.64 0.0715
2021-11-24 2021-09-30 NP Relay Therapeutics EC US75943R1023 90,454 2,016 2.28 2,852 -11.84 0.0628
2021-08-26 2021-06-30 NP Relay Therapeutics EC US75943R1023 88,438 19,209 27.75 3,236 35.19 0.0694
2021-05-27 2021-03-31 NP Relay Therapeutics EC US75943R1023 69,229 18,827 37.35 2,393 14.28 0.0543
2021-02-25 2020-12-31 NP Relay Therapeutics EC US75943R1023 50,402 -2,008 -3.83 2,095 -6.18 0.0537
2020-11-25 2020-09-30 NP Relay Therapeutics EC US75943R1023 52,410 52,410 2,232 0.0716
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.